Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors.

Heuser, Alisa, Abdul Rahman, Wassim, Bechter, Elisabeth, Blank, Jutta, Buhr, Sylvia, Fontana, Patrizia, Meyerhofer, Marco, Strang, Ross, Schrapp, Maxime, Zimmermann, Catherine, Cortes-Cros, Marta, Moebitz, Henrik, Hamon, Jacques, Mermet-Meillon, Fanny and Erdmann, Dirk (2024) Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors. ChemMedChem.


The Werner Syndrome RecQ helicase (WRN) is a synthetic lethal target of interest for the treatment of cancers with microsatellite instability (MSI). Different hit finding approaches were initially tested. The identification of WRN inhibitors proved challenging due to a high propensity for artefacts via protein interference, i. e., hits inhibiting WRN enzymatic activities through multiple, unspecific mechanisms. Previously published WRN Helicase inhibitors (ML216, NSC19630 or NSC617145) were characterized in an extensive set of biochemical and biophysical assays and could be ruled out as specific WRN helicase probes. More innovative screening strategies need to be developed for successful drug discovery of non-covalent WRN helicase inhibitors.

Item Type: Article
Date Deposited: 30 Mar 2024 00:45
Last Modified: 30 Mar 2024 00:45